UNITED STATES RHEUMATOLOGY PRACTICE BASED REAL-WORLD EVIDENCE OF METHOTREXATE UTILIZATION AND RESPONSE TO THERAPY IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH INTRAVENOUS GOLIMUMAB: 52-WEEK FROM THE AWARE STUDY

被引：0

作者：

Broadwell, Aaron ^{[1
]}

Schechtman, Joy ^{[2
]}

Conaway, Douglas ^{[3
]}

Kivitz, Alan ^{[4
]}

Black, Shawn ^{[5
]}

Xu, Stephen ^{[6
]}

Langholff, Wayne ^{[6
]}

Zazzetti, Federico ^{[7
]}

Kafka, Shelly ^{[5
]}

机构：

[1] Rheumatol & Osteoporosis Specialists, Shreveport, LA USA

[2] SunValley Arthrit Ctr, Peoria, IL USA

[3] Grand Strand Reg Med, Myrtle Beach, SC USA

[4] Altoona Ctr Clin Res, Duncansville, PA USA

[5] Janssen Sci Affairs LLG, Horsham, PA USA

[6] Janssen Res & Dev LLC, Spring House, PA USA

[7] Janssen LATAM Med Affairs, Buenos Aires, DF, Argentina

来源：

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY | 2020年 / 26卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

132

引用

页码：82 / 82

页数：1

共 36 条

[21] Real-world effectiveness of golimumab in adult patients with rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis and an inadequate response to initial TNFi therapy in Greece: the GO-BEYOND prospective, observational study
Panagiotis Athanassiou
Dimitrios Psaltis
Athanasios Georgiadis
Gkikas Katsifis
Athina Theodoridou
Souzana Gazi
Prodromos Sidiropoulos
Maria G. Tektonidou
Andreas Bounas
Anna Kandyli
Periklis Vounotrypidis
Grigorios T. Sakellariou
Dimitrios Vassilopoulos
Zhiping Huang
Evangelia Petrikkou
Dimitrios Boumpas
Rheumatology International, 2023, 43 : 1871 - 1883
[22] Real-world effectiveness of golimumab in adult patients with rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis and an inadequate response to initial TNFi therapy in Greece: the GO-BEYOND prospective, observational study
Athanassiou, Panagiotis
Psaltis, Dimitrios
Georgiadis, Athanasios
Katsifis, Gkikas
Theodoridou, Athina
Gazi, Souzana
Sidiropoulos, Prodromos
Tektonidou, Maria G. G.
Bounas, Andreas
Kandyli, Anna
Vounotrypidis, Periklis
Sakellariou, Grigorios T. T.
Vassilopoulos, Dimitrios
Huang, Zhiping
Petrikkou, Evangelia
Boumpas, Dimitrios
RHEUMATOLOGY INTERNATIONAL, 2023, 43 (10) : 1871 - 1883
[23] BASELINE CHARACTERISTICS OF PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH UPADACITINIB IN GERMAN REAL-WORLD PRACTICE: RESULTS FROM THE POST-MARKETING OBSERVATIONAL UPWARDS STUDY
Witte, T.
Kiltz, U.
Haas, F.
Riechers, E.
Prothmann, U.
Adolf, D.
Holland, C.
Hecht, R.
Roessler, A.
Famulla, K.
Kruegeron, K.
ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1153 - 1154
[24] Clinical response among golimumab-treated Japanese patients with rheumatoid arthritis by number of previous biologic therapies: Real-world evidence frompost-hocanalysis of post-marketing surveillance data
Shimizu, Hirohito
Kobayashi, Hisanori
Kanbori, Masayoshi
Ishii, Yutaka
MODERN RHEUMATOLOGY, 2021, 31 (03) : 566 - 574
[25] EFFICACY AND SAFETY OF BARICITINIB VERSUS PLACEBO AND ADALIMUMAB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE TO METHOTREXATE: SUMMARY RESULTS FROM THE 52-WEEK PHASE 3 RA-BEAM STUDY
Taylor, Peter C.
Krogulec, Marek
Dudek, Anna
Dudler, Jean
Drescher, Edit
Cseuz, Regina
Kausiene, Rasa
Andersone, Daina
Unikiene, Dalia
Sanchez Burson, Juan
Blanco Alonso, Ricardo
Dvorak, Zdenek
Ghizdavescu, Andrei
Irto, Ildiko
Larsson, Esbjorn
Bello, Natalia
Barry, Jane
Durand, Frederick
Holzkaemper, Thorsten
Otawa, Susan
de Bono, Stephanie
Keystone, Edward C.
Rubbert-Roth, Andrea
Combe, Bernard
De La Torre, Inmaculada
RHEUMATOLOGY, 2017, 56 : 26 - 27
[26] Long-term efficacy and safety of certolizumab pegol in Japanese rheumatoid arthritis patients with an inadequate response to methotrexate: 52-week results from an open-label extension of the J-RAPID study
Tanaka, Yoshiya
Yamamoto, Kazuhiko
Takeuchi, Tsutomu
Yamanaka, Hisashi
Ishiguro, Naoki
Eguchi, Katsumi
Watanabe, Akira
Origasa, Hideki
Shoji, Toshiharu
Miyasaka, Nobuyuki
Koike, Takao
MODERN RHEUMATOLOGY, 2014, 24 (05) : 734 - 743
[27] CONSTRUCT VALIDATION OF PROMIS SHORT FORM AND PROFILE-29 T-SCORES WITH SF-36 IN RHEUMATOID ARTHRITIS PATIENTS TREATED FOR 1 YEAR: RESULTS FROM A REAL-WORLD EVIDENCE-BASED STUDY IN THE UNITED STATES
Bingham, C.
Kafka, S.
Black, S.
Xu, S.
Langholff, W.
Curtis, J.
ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 882 - 882
[28] Real-World Evidence of the Antifibrotic Nintedanib in Rheumatoid Arthritis-Interstitial Lung Disease. National Multicenter Study of 74 Patients from Clinical Practice
Atienza-Mateo, Belen
Serrano-Combarro, Ana
Loarce, Jesus
Vegas Revenga, Nuria
Martin Lopez, Maria
Castaneda, Santos
Melero-Gonzalez, Rafael Benito
Mena Vazquez, Natalia
Carrasco-Cubero, Carmen
Diez Morrondo, Carolina
Castro-Corredor, David
Vazquez Rodriguez, Tomas
Garcia-Valle, Andrea
Bonilla, Gema
Rodriguez, Marina
Brana Abascal, Ignacio
Rojas Herrera, Sara Maria
Sarmiento-Monroy, Juan Camilo
Andujar-Brazal, Pablo
Ferrer, Diego
Blanco-Alonso, Ricardo
ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 4593 - 4595
[29] The comparison of efficacy and safety between etanercept (ETN) plus methotrexate (MTX) combination therapy and ETN monotherapy in MTX-refractory Japanese patients with rheumatoid arthritis: 52-week clinical results from the JESMR study
Kameda, Hideto
Ueki, Yukitaka
Saito, Kazuyoshi
Nagaoka, Shouhei
Hidaka, Toshihiko
Atsumi, Tatsuya
Tsukano, Michishi
Kasama, Tsuyoshi
Shiozawa, Shunichi
Tanaka, Yoshiya
Takeuchi, Tsutomu
ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S531 - S531
[30] Construct Validation of PROMIS Short Form and Profile-29 T-Scores with SF-36 in Rheumatoid Arthritis Patients Treated for 1 Year: Results from a Real World Evidence-Based Study in the United States
Bingham, Clifton
Kafka, Shelly
Black, Shawn
Xu, Stephen
Curtis, Jeffrey
ARTHRITIS & RHEUMATOLOGY, 2019, 71

← 1 2 3 4 →